Up­dat­ed: ES­MO em­bar­go break leads can­cer con­fer­ence to re­lease da­ta for Bris­tol My­ers, J&J, No­var­tis, As­traZeneca

A bro­ken em­bar­go on the high­est-pro­file ab­stracts at this year’s Eu­ro­pean So­ci­ety for Med­ical On­col­o­gy has forced the con­fer­ence or­ga­niz­er to re­lease da­ta from the pre­sen­ta­tions sev­er­al days ear­ly.

Tues­day’s de­ci­sion by ES­MO was made ahead of the on­col­o­gy meet­ing in Madrid this week­end. Con­fer­ence or­ga­niz­ers said the call was made to re­lease the late-break­ing ab­stracts to “en­sure fair and eq­ui­table ac­cess to all da­ta to all rel­e­vant par­ties.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER